Enhancing healthcare quality and outcomes for peritoneal dialysis patients in Thailand: An evaluation of key performance indicators and PDOPPS cohort representativeness.


Journal

Nephrology (Carlton, Vic.)
ISSN: 1440-1797
Titre abrégé: Nephrology (Carlton)
Pays: Australia
ID NLM: 9615568

Informations de publication

Date de publication:
Aug 2023
Historique:
accepted: 14 06 2023
medline: 4 8 2023
pubmed: 3 8 2023
entrez: 3 8 2023
Statut: ppublish

Résumé

To assess whether the peritoneal dialysis (PD) centres included in the Peritoneal Dialysis Outcomes and Practise Patterns Study (PDOPPS) in Thailand are representative of other PD centres in the country, based on 8 key performance indicators (KPIs 1-8). A retrospective analysis was conducted comparing PD-related clinical outcomes between PD centres included in the PDOPPS (the PDOPPS group) and those not included (the non-PDOPPS group) from January 2018 to December 2019. Logistic regression analysis was used to identify predictors associated with achieving the target KPIs. Of 181 PD centres, 22 (12%) were included in the PDOPPS. PD centres in the PDOPPS group were larger and tended to serve more PD patients than those in the non-PDOPPS group. However, the process and outcome KPIs (KPIs 1-8) were comparable between the 2 groups. Large hospitals (≥120 beds), providing care to ≥100 PD cases and having experience for >10 years were independent predictors of achieving the peritonitis rate target of <0.5 episodes/year. Most PD centres in Thailand showed weaknesses in off-target haemoglobin levels and culture-negative peritonitis rate. The PD centres included in Thai PDOPPS were found to be representative of other PD centres in Thailand in terms of clinical outcomes. Thus, Thai PDOPPS findings may apply to the broader PD population in Thailand.

Identifiants

pubmed: 37534842
doi: 10.1111/nep.14204
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

14-23

Subventions

Organisme : Thailand Science Research and Innovation Fund Chulalongkorn University
ID : CU_FRB65_hea (19)_026_30_07
Organisme : Ratchadapiseksompotch Fund Chulalongkorn University
ID : HEA663000116
Organisme : Ratchadapiseksompotch Fund Chulalongkorn University
ID : HEA663000115

Informations de copyright

© 2023 Asian Pacific Society of Nephrology.

Références

Kanjanabuch T, Takkavatakarn K. Global dialysis perspective: Thailand. Kidney360. 2020;1:671-675.
TRT. Thai Renal Replacement Therapy Report 2015. 2015. Accessed April 20, 2023 nephrothai.org, http://www.nephrothai.org/images/Final_TRT_report_2015_%E0%B8%89%E0%B8%9A%E0%B8%9A%E0%B9%81%E0%B8%81%E0%B9%84%E0%B8%82.pdf
Dhanakijcharoen P, Sirivongs D, Aruyapitipan S, Chuengsaman P, Lumpaopong A. The "PD first" policy in Thailand: three-years experiences (2008-2011). J Med Assoc Thai. 2011;94(4):S153-S161.
Perl J, Davies SJ, Lambie M, et al. The peritoneal dialysis outcomes and practice patterns study (PDOPPS): unifying efforts to inform practice and improve global outcomes in peritoneal dialysis. Perit Dial Int. 2016;36:297-307.
Pongpirul K, Kanjanabuch T, Puapatanakul P, et al. National feasibility survey of peritoneal dialysis key performance indicators in Thailand from provider perspective. Nephrology (Carlton). 2020;25:483-490.
Kanjanabuch T, Puapatanakul P, Halue G, et al. Implementation of PDOPPS in a middle-income country: early lessons from Thailand. Perit Dial Int. 2022;42:83-91.
Puapatanakul P, Kanjanabuch T, Tungsanga K, et al. Assisted peritoneal dialysis performed by caregivers and its association with patient outcomes. Perit Dial Int. 2022;42(6):602-614.
Cheawchanwattana A, Kanjanabuch T, Puapatanakul P, et al. Spiritual well-being and its relationship with patient characteristics and other patient-reported outcomes in peritoneal dialysis patients: findings from the PDOPPS. Nephrology (Carlton). 2022;27(7):621-631.
Cheetham MS, Zhao J, McCullough K, et al. International peritoneal dialysis training practices and the risk of peritonitis. Nephrol Dial Transplant. 2022;37(5):937-949.
Lambie M, Zhao J, McCullough K, et al. Variation in peritoneal dialysis time on therapy by country: results from the peritoneal dialysis outcomes and practice patterns study. Clin J Am Soc Nephrol. 2022;17(6):861-871.
Li PK, Chow KM, Cho Y, et al. ISPD peritonitis guideline recommendations: 2022 update on prevention and treatment. Perit Dial Int. 2022;42:110-153.
Brown EA, Blake PG, Boudville N, et al. International society for peritoneal dialysis practice recommendations: prescribing high-quality goal-directed peritoneal dialysis. Perit Dial Int. 2020;40:244-253.
Ethier I, Boudville N, McDonald S, et al. Representativeness of the PDOPPS cohort compared to the Australian PD population. Perit Dial Int. 2021;42:403-414.
Fang W, Ni Z, Qian J. Key factors for a high-quality peritoneal dialysis program - the role of the PD team and continuous quality improvement. Perit Dial Int. 2014;34(2):S35-S42.
Toussaint ND, McMahon LP, Dowling G, et al. Implementation of renal key performance indicators: promoting improved clinical practice. Nephrol Ther. 2015;20:184-193.
Yu Y, Zhou Y, Wang H, et al. Impact of continuous quality improvement initiatives on clinical outcomes in peritoneal dialysis. Perit Dial Int. 2014;34(2):S43-S48.
Mudge DW, Boudville N, Brown F, et al. Peritoneal dialysis practice in Australia and New Zealand: a call to sustain the action. Nephrol Ther. 2016;21:535-546.
South Australian Renal Clinical Network. South Australian Statewide Renal Key Performance Indicators. 2014. Accessed April 20, 2023 https://www.sahealth.sa.gov.au/wps/wcm/connect/9010bd80453022288e54de005ba75f87/SA-Renal-KPI%27s-Feb-2014-final.pdf?MOD=AJPERES&amp;CACHEID=ROOTWORKSPACE-9010bd80453022288e54de005ba75f87-nwJXBiG
UK Kidney Association. 24th Annual Report. Chapter 6 Adults on PD in the UK at the end of 2020. 2020. Accessed April 20, 2023 https://ukkidney.org/sites/renal.org/files/24th_UKRR_ANNUAL_REPORT_PD_Ch6.pdf
Kanjanabuch T, Chatsuwan T, Udomsantisuk N, et al. Association of local unit sampling and microbiology laboratory culture practices with the ability to identify causative pathogens in peritoneal dialysis-associated peritonitis in Thailand. Kidney Int Rep. 2021;6:1118-1129.
Perl J, Fuller DS, Bieber BA, et al. Peritoneal dialysis-related infection rates and outcomes: results from the peritoneal dialysis outcomes and practice patterns study (PDOPPS). Am J Kidney Dis. 2020;76:42-53.
Al Sahlawi M, Zhao J, McCullough K, et al. Variation in peritoneal dialysis-related peritonitis outcomes in the peritoneal dialysis outcomes and practice patterns study (PDOPPS). Am J Kidney Dis. 2022;79(1):45-55.e123.
Figueiredo AE, de Souza UJ, Bernardini J, Vieira KL. Determining nurse staffing for peritoneal dialysis care. Nephrol Nurs J. 2016;43:30550070.
Htay H, Cho Y, Pascoe EM, et al. Center effects and peritoneal dialysis peritonitis outcomes: analysis of a National Registry. Am J Kidney Dis. 2018;71:814-821.
Lopes MB, Karaboyas A, Zhao J, et al. Association of single and serial measures of serum phosphorus with adverse outcomes in patients on peritoneal dialysis: results from the international PDOPPS. Nephrol Dial Transplant. 2023;38:193-202.
Wang AY, Zhao J, Bieber B, et al. International comparison of peritoneal dialysis prescriptions from the peritoneal dialysis outcomes and practice patterns study (PDOPPS). Perit Dial Int. 2020;40(3):310-319.
Tennankore K, Zhao J, Karaboyas A, et al. The association of functional status with mortality and dialysis modality change: results from the peritoneal dialysis outcomes and practice patterns study (PDOPPS). Perit Dial Int. 2019;39(2):103-111.
Boudville N, Johnson DW, Zhao J, et al. Regional variation in the treatment and prevention of peritoneal dialysis-related infections in the peritoneal dialysis outcomes and practice patterns study. Nephrol Dial Transplant. 2019;34(12):2118-2126.

Auteurs

Sarinya Boongird (S)

Division of Nephrology, Department of Medicine, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.

Jeerath Phannajit (J)

Division of Nephrology, Department of Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
Division of Clinical Epidemiology, Department of Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.

Talerngsak Kanjanabuch (T)

Division of Nephrology, Department of Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
Center of Excellence in Kidney Metabolic Disorders, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
Peritoneal Dialysis Excellent Center, King Chulalongkorn Memorial Hospital, Bangkok, Thailand.

Piyatida Chuengsaman (P)

Banphaeo-Charoenkrung Peritoneal Dialysis Centre, Banphaeo Dialysis Group, Banphaeo Hospital, Bangkok, Thailand.

Phongsak Dandecha (P)

Division of Nephrology, Department of Internal Medicine, Prince of Songkla University, Hat Yai, Songkhla, Thailand.

Guttiga Halue (G)

Department of Medicine, Phayao Hospital, Phayao, Thailand.

Pichet Lorvinitnun (P)

Department of Medicine, Sunpasitthiprasong Hospital, Ubon Ratchathani, Thailand.

Chanchana Boonyakrai (C)

Department of Medicine, King Taksin Memorial Hospital, Bangkok Metropolitan Administration, Bangkok, Thailand.

Worapot Treamtrakanpon (W)

Department of Medicine, Chaopraya Abhaibhubejhr Hospital, Prachin Buri, Thailand.

Sajja Tatiyanupanwong (S)

Division of Nephrology, Department of Internal Medicine, Chaiyaphum Hospital, Chaiyaphum, Thailand.

Niwat Lounseng (N)

Division of Medicine, Trang Hospital, Trang, Thailand.

Jeffrey Perl (J)

Division of Nephrology and Keenan Research Center, Li Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto, Ontario, Canada.

David W Johnson (DW)

Department of Kidney and Transplant Services, Division of Medicine, Princess Alexandra Hospital, Woolloongabba, Queensland, Australia.
Australasian Kidney Trials Network, Centre of Health Services Research, University of Queensland, Brisbane, Australia.
Centre of Kidney Disease Research, Translational Research Institute, Brisbane, Australia.

Roberto Pecoits-Filho (R)

Pontifical Catholic University of Parana, Curitiba, Brazil.
Arbor Research Collaborative for Health, Ann Arbor, Michigan, USA.

Suchai Sritippayawan (S)

Division of Nephrology, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.

Kriang Tungsanga (K)

Division of Nephrology, Department of Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.

Surasak Kantachuvesiri (S)

Division of Nephrology, Department of Medicine, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.

Vuddhidej Ophascharoensuk (V)

Division of Nephrology, Department of Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH